Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease.
Boursier J, Vergniol J, Guillet A, Hiriart JB, Lannes A, Le Bail B, Michalak S, Chermak F, Bertrais S, Foucher J, Oberti F, Charbonnier M, Fouchard-Hubert I, Rousselet MC, Calès P, de Lédinghen V. Boursier J, et al. Among authors: lannes a. J Hepatol. 2016 Sep;65(3):570-8. doi: 10.1016/j.jhep.2016.04.023. Epub 2016 May 2. J Hepatol. 2016. PMID: 27151181
Criteria to Determine Reliability of Noninvasive Assessment of Liver Fibrosis With Virtual Touch Quantification.
Boursier J, Cassinotto C, Hunault G, Shili S, Lebigot J, Lapuyade B, Lannes A, Hiriart JB, Cartier V, Le Bail B, Michalak S, Mouries A, Oberti F, Chermak F, Fouchard-Hubert I, Cales P, Aube C, de Ledinghen V. Boursier J, et al. Among authors: lannes a. Clin Gastroenterol Hepatol. 2019 Jan;17(1):164-171.e5. doi: 10.1016/j.cgh.2018.04.062. Epub 2018 May 9. Clin Gastroenterol Hepatol. 2019. PMID: 29753082
Circulating PCSK9 levels are not associated with the severity of hepatic steatosis and NASH in a high-risk population.
Wargny M, Ducluzeau PH, Petit JM, Le May C, Smati S, Arnaud L, Pichelin M, Bouillet B, Lannes A, Blanchet O, Lefebvre P, Francque S, Van Gaal L, Staels B, Vergès B, Boursier J, Cariou B. Wargny M, et al. Among authors: lannes a. Atherosclerosis. 2018 Nov;278:82-90. doi: 10.1016/j.atherosclerosis.2018.09.008. Epub 2018 Sep 13. Atherosclerosis. 2018. PMID: 30261472
Liver Stiffness Measurement With FibroScan: Use the Right Probe in the Right Conditions!
Berger A, Shili S, Zuberbuhler F, Hiriart JB, Lannes A, Chermak F, Hunault G, Foucher J, Oberti F, Fouchard-Hubert I, Cales P, de Ledinghen V, Boursier J. Berger A, et al. Among authors: lannes a. Clin Transl Gastroenterol. 2019 Apr;10(4):e00023. doi: 10.14309/ctg.0000000000000023. Clin Transl Gastroenterol. 2019. PMID: 31009403 Free PMC article. Clinical Trial.
New sequential combinations of non-invasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD.
Boursier J, Guillaume M, Leroy V, Irlès M, Roux M, Lannes A, Foucher J, Zuberbuhler F, Delabaudière C, Barthelon J, Michalak S, Hiriart JB, Peron JM, Gerster T, Le Bail B, Riou J, Hunault G, Merrouche W, Oberti F, Pelade L, Fouchard I, Bureau C, Calès P, de Ledinghen V. Boursier J, et al. Among authors: lannes a. J Hepatol. 2019 Aug;71(2):389-396. doi: 10.1016/j.jhep.2019.04.020. Epub 2019 May 16. J Hepatol. 2019. PMID: 31102719
Direct comparison of the specialised blood fibrosis tests FibroMeterV2G and Enhanced Liver Fibrosis score in patients with non-alcoholic fatty liver disease from tertiary care centres.
Guillaume M, Moal V, Delabaudiere C, Zuberbuhler F, Robic MA, Lannes A, Metivier S, Oberti F, Gourdy P, Fouchard-Hubert I, Selves J, Michalak S, Peron JM, Cales P, Bureau C, Boursier J. Guillaume M, et al. Among authors: lannes a. Aliment Pharmacol Ther. 2019 Dec;50(11-12):1214-1222. doi: 10.1111/apt.15529. Epub 2019 Oct 15. Aliment Pharmacol Ther. 2019. PMID: 31617224
42 results